Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing early ejaculation: what does the future hold?

Michael P O'leary

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Premature ejaculation (PE) is common and may be treated with medications like sildenafil and SSRIs. Further research is needed for FDA approval, but new treatment options for male sexual dysfunction are emerging.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Great Debates: De-Escalation of Standardized Testing in Medical Education (USMLE Pass/Fail, De-Emphasizing Shelf Exams and ABSITE Scores) Has Been a Positive Evolution in Medical Education.

    The American surgeon·2026
    Same author

    Association of Obesity With Respiratory Complications in Trauma Patients Undergoing Emergent Surgery.

    The Journal of surgical research·2026
    Same author

    Regional Therapies Utilized in Treating Unresectable Colorectal Adenocarcinoma with Peritoneal Metastases.

    Cancers·2026
    Same author

    A rare presentation of Merkel cell carcinoma in a young immunocompetent woman.

    JAAD case reports·2026
    Same author

    ASO Visual Abstract: Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric Cancer.

    Annals of surgical oncology·2025
    Same author

    Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric Cancer.

    Annals of surgical oncology·2025
    Same journal

    Erratum: Author's Name Correction for "From Radical to Partial Nephrectomy in the Setting of Solitary Functioning Kidney: Neoadjuvant Treatment of Renal Cell Carcinoma".

    Reviews in urology·2021
    Same journal

    Update in Female Hormonal Therapy: What the Urologist Should Know: NYU Case of the Month, December 2020.

    Reviews in urology·2021
    Same journal

    Genetic Mutations Associated With Prostate Cancer and Normal Serum PSA and DRE-Implications for Prostate Cancer Screening and Management: NYU Case of the Month, November 2020.

    Reviews in urology·2021
    Same journal

    Surgical Management of the "Large" Prostate: The Robotic Simple Prostatectomy: NYU Case of the Month, October 2020.

    Reviews in urology·2021
    Same journal

    Cryptozoospermia Associated With Genital Tucking Behavior in a Transwoman.

    Reviews in urology·2021
    Same journal

    Washington Roundup.

    Reviews in urology·2021
    See all related articles

    Area of Science:

    • Urology
    • Andrology
    • Pharmacology

    Background:

    • Erectile dysfunction (ED) has received significant research attention, overshadowing other male sexual dysfunctions.
    • Premature ejaculation (PE) is a highly prevalent condition affecting a substantial number of men.
    • Historically, PE was primarily considered a behavioral issue managed with control techniques.

    Purpose of the Study:

    • To explore the clinical study and pharmacologic treatment of premature ejaculation (PE).
    • To review the current understanding of PE and its potential therapeutic interventions.
    • To highlight the need for further research into effective treatments for PE.

    Main Methods:

    • Review of existing literature on premature ejaculation treatments.
    • Analysis of the efficacy of current medications (e.g., sildenafil, SSRIs) for PE.

    Related Experiment Videos

  • Discussion of the evolving understanding of PE from a behavioral to a potentially pharmacologic condition.

    • Main Results:

    • Some existing drugs, including sildenafil and selective serotonin reuptake inhibitors (SSRIs), show potential efficacy in treating PE.
    • Current pharmacologic options suggest a shift from purely behavioral management to medical interventions.
    • Evidence indicates that medications may offer viable treatment avenues for PE.

    Conclusions:

    • While not yet FDA-approved for PE, certain medications demonstrate promise for managing this condition.
    • Increased research focus on ejaculatory disorders is expected to yield improved treatment options for men.
    • Reducing the stigma associated with PE is crucial for encouraging men to seek and benefit from clinical study and treatment.